Does ROSUVASTATIN Cause Cardiogenic shock? 73 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Cardiogenic shock have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
73
Reports of Cardiogenic shock with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
29
Deaths
21
Hospitalizations
How Dangerous Is Cardiogenic shock From ROSUVASTATIN?
Of the 73 reports, 29 (39.7%) resulted in death, 21 (28.8%) required hospitalization, and 21 (28.8%) were considered life-threatening.
Is Cardiogenic shock Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Cardiogenic shock?
AMLODIPINE (779)
AMIODARONE (595)
BUPROPION (559)
ACETAMINOPHEN (466)
METOPROLOL (454)
BISOPROLOL (413)
VERAPAMIL (412)
NOREPINEPHRINE (381)
HEPARIN (357)
METFORMIN (356)
Which ROSUVASTATIN Alternatives Have Lower Cardiogenic shock Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN